Overview
- 3 FDA inspections are on record.
- 3 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-02-27.
At a glance
Inspections
3
Form 483s
3
EIRs
2
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 19 Feb 2025 – 27 Feb 2025 | Human Drugs | 483 | View 483 → |
| 11 Jul 2022 – 15 Jul 2022 | Human Drugs | 483 | On file |
| 21 Jun 2021 – 2 Jul 2021 | Human Drugs | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
27 Feb 2025
21 CFR 211.160(b)
Scientifically sound laboratory controls
Cited by Linda Thai, Philip F Istafanos
Investigators
FDA investigators tied to this site in the record.
Linda Thai1 insp.
Philip F Istafanos1 insp.
Patricia F Hughes Troost1 insp.
Virginia A Carroll1 insp.
Sarah A Johnson1 insp.
Carla J Lundi1 insp.
Joao A Pedras Vasconcel1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Revance Therapeutics, Inc.'s 3 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat